Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,733,816
  • Shares Outstanding, K 44,230
  • Annual Sales, $ 236,980 K
  • Annual Income, $ 15,420 K
  • 60-Month Beta 1.78
  • Price/Sales 7.00
  • Price/Cash Flow 239.54
  • Price/Book 2.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.69
  • Number of Estimates 5
  • High Estimate -0.22
  • Low Estimate -0.87
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -527.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.10 +15.54%
on 05/15/20
44.28 -11.02%
on 05/06/20
+4.40 (+12.57%)
since 04/27/20
3-Month
23.31 +69.03%
on 03/23/20
46.05 -14.44%
on 03/03/20
-22.07 (-35.90%)
since 02/27/20
52-Week
23.31 +69.03%
on 03/23/20
84.65 -53.46%
on 08/01/19
-26.09 (-39.84%)
since 05/24/19

Most Recent Stories

More News
Glaukos Corp (GKOS)

SmarTrend identified a Downtrend for Glaukos Corp (NYSE:GKOS) on April 1st, 2020 at $29.40. In approximately 1 month, Glaukos Corp has returned 19.51% as of today's recent price of $35.13.

GKOS : 39.53 (+0.84%)
Glaukos Technologies Featured in Numerous Presentations at the 2020 American Society of Cataract and Refractive Surgery Virtual Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...

GKOS : 39.53 (+0.84%)
Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates

Glaukos (GKOS) witnessed a contraction in gross margin but year-over-year revenue surge in Q1.

BIIB : 296.77 (+0.30%)
LLY : 144.62 (-2.26%)
GKOS : 39.53 (+0.84%)
APHA : 4.11 (-2.61%)
Glaukos Corp (GKOS)

SmarTrend identified a Downtrend for Glaukos Corp (NYSE:GKOS) on April 1st, 2020 at $29.40. In approximately 1 month, Glaukos Corp has returned 38.49% as of today's recent price of $40.71.

GKOS : 39.53 (+0.84%)
Glaukos (GKOS) Reports Q1 Loss, Misses Revenue Estimates

Glaukos (GKOS) delivered earnings and revenue surprises of -25.71% and -0.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 39.53 (+0.84%)
Glaukos: 1Q Earnings Snapshot

SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Thursday reported a loss of $54.1 million in its first quarter.

GKOS : 39.53 (+0.84%)
Glaukos Corporation Announces First Quarter 2020 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 39.53 (+0.84%)
% Return Seen to Date on SmarTrend Glaukos Corp Call (GKOS)

SmarTrend identified a Downtrend for Glaukos Corp (NYSE:GKOS) on April 1st, 2020 at $29.40. In approximately 4 weeks, Glaukos Corp has returned 25.02% as of today's recent price of $36.75.

GKOS : 39.53 (+0.84%)
Global Cataract Surgery Devices Market 2020: Latest In-Depth Report Segment by Manufacturers, Type, Applications and Dynamics

A recent report provides crucial insights along with application based and forecast information in the Global Cataract Surgery Devices Market. The report provides a comprehensive analysis of key factors...

ABT : 89.57 (+0.10%)
AGN : 193.02 (+0.02%)
CZMWF : 93.0396 (-2.06%)
GKOS : 39.53 (+0.84%)
NVS : 84.18 (-1.02%)
STAA : 39.51 (-0.50%)
TOPCF : 8.2200 (+1.61%)
VRX.TO : 30.80 (-3.33%)
Glaukos Corporation to Release First Quarter 2020 Financial Results after Market Close on May 7

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to...

GKOS : 39.53 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GKOS with:

Business Summary

Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe,...

See More

Key Turning Points

2nd Resistance Point 40.66
1st Resistance Point 39.93
Last Price 39.53
1st Support Level 38.37
2nd Support Level 37.54

See More

52-Week High 84.65
Fibonacci 61.8% 61.22
Fibonacci 50% 53.98
Fibonacci 38.2% 46.74
Last Price 39.53
52-Week Low 23.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar